Rankings
▼
Calendar
ATYR Q4 2024 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena
ATYR
aTyr Pharma, Inc.
$93M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$12M
Operating Income
-$16M
Net Income
-$15M
EPS (Diluted)
$-0.18
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$770,000
Balance Sheet
Total Assets
$97M
Total Liabilities
$27M
Stockholders' Equity
$70M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$12M
-$407,000
-2904.4%
Operating Income
-$16M
-$16M
+0.9%
Net Income
-$15M
-$15M
-1.4%
← FY 2024
All Quarters
Q1 2025 →